跳至主要内容
临床试验/EUCTR2020-002453-26-DK
EUCTR2020-002453-26-DK进行中(未招募)1 期

Eight weeks of androgen priming by hCG before IVF/ICSI in women with low ovarian reserve. - hCG priming in women with low ovarian reserve

Rigshospitalet0 个研究点目标入组 20 人开始时间: 2020年6月9日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Age 18-40 (both inclusive); regular menstrual cycle between 23 and 35 days; AMH < 6.29 pmol/L, willingness to undergo two consecutive identical controlled ovarian stimulations with a freeze-all strategy employed after the first stimulation.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria are uterine malformations, submucosal myomas, intrauterine polyps, hydrosalpinx, endometriosis stage III-IV, severe comorbidity (i.e. IDDM, NIDDM, gastrointestinal, cardiovascular, pulmonary, liver or kidney diseases, HIV or Hepatitis B/C, dysregulation of thyroid disease), need for testicular sperm aspiration, preimplantation genetic testing, not Danish or English speaking, previous inclusion, or allergy to Ovitrelle or other standard IVF medication.

研究者

相似试验